Babata Kikelomo, Sultana Rehena, Hascoët Jean-Michel, Albert Riya, Chan Christina, Mazzarella Kelly, Muhamed Tanaz, Yeo Kee Thai, Kong Juin Yee, Brion Luc P
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA.
Centre for Quantitative Medicine, Duke-NUS Medical School, Singapore 169857, Singapore.
J Clin Med. 2025 Jan 6;14(1):280. doi: 10.3390/jcm14010280.
The risk of neonatal SARS-CoV-2 infection from the mother's own milk (MoM) in neonates who are exposed to maternal SARS-CoV-2 during the perinatal period remains unclear. We conducted a systematic review to assess the association between MoM feeding and neonatal SARS-CoV-2 infection in neonates who were born to SARS-CoV-2-positive pregnant persons. PubMed Central and Google Scholar were searched for studies published by 14 March 2024 that reported neonatal SARS-CoV-2 infection by feeding type. This search, including Scopus, was updated on 17 December 2024. The primary outcome was neonatal SARS-CoV-2 infection. The meta-analysis was conducted using a random effects model with two planned subgroup analyses: time of maternal PCR testing (at admission vs. previous 2 weeks) and dyad handling (isolation vs. some precautions vs. variable/NA). The primary outcome was available in both arms of nine studies, including 5572 neonates who received MoM and 2215 who received no MoM. The GRADE rating was low quality, because the studies were observational (cohorts). The frequency of SARS-CoV-2 infection was similar in both arms (2.7% MoM vs. 2.2% no MoM), with a common risk ratio of 0.82 (95% confidence interval 0.44, 1.53, = 0.54). No significant differences were observed in the subgroup analyses. Limitations include observational and incomplete data, other possible infection sources, small sample sizes for subgroup analyses, and neonates with more than one feeding type. Feeding MoM was not associated with an increased risk of neonatal SARS-CoV-2 infection among neonates who were born to mothers with perinatal infection. These data, along with reports showing a lack of active replicating SARS-CoV-2 virus in MoM, further support women with perinatal SARS-CoV-2 infection feeding MoM. Registration: PROSPERO ID CRD42021268576.
在围产期接触母体SARS-CoV-2的新生儿中,通过母乳感染新生儿SARS-CoV-2的风险尚不清楚。我们进行了一项系统综述,以评估在SARS-CoV-2阳性孕妇所生新生儿中,母乳喂养与新生儿SARS-CoV-2感染之间的关联。检索了PubMed Central和谷歌学术,查找截至2024年3月14日发表的、按喂养类型报告新生儿SARS-CoV-2感染情况的研究。该检索(包括Scopus)于2024年12月17日更新。主要结局是新生儿SARS-CoV-2感染。使用随机效应模型进行荟萃分析,并进行两项计划中的亚组分析:母体PCR检测时间(入院时与前2周)和母婴处理方式(隔离与采取一些预防措施与可变/无信息)。九项研究的两组均有主要结局数据,包括5572名接受母乳喂养的新生儿和2215名未接受母乳喂养的新生儿。GRADE评级为低质量,因为这些研究为观察性研究(队列研究)。两组中SARS-CoV-2感染的频率相似(母乳喂养组为2.7%,非母乳喂养组为2.2%),共同风险比为0.82(95%置信区间0.44,1.53,P = 0.54)。亚组分析未观察到显著差异。局限性包括观察性研究和不完整数据、其他可能的感染源、亚组分析样本量小以及有多种喂养类型的新生儿。在围产期感染的母亲所生的新生儿中,母乳喂养与新生儿SARS-CoV-2感染风险增加无关。这些数据,连同显示母乳中缺乏活跃复制的SARS-CoV-2病毒的报告,进一步支持围产期感染SARS-CoV-2的女性进行母乳喂养。注册信息:PROSPERO ID CRD42021268576